Novartis CEO criticizes German health reform: 'A wrong signal'

Germany wants to save billions with larger price reductions on medicines. Meanwhile, the pharmaceutical company has to allay investors' concerns about patent expiries.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

nzzGerman111d ago

Novartis-Chef kritisiert die deutsche Gesundheitsreform: «Ein falsches Signal»

Mit grösseren Preisabschlägen auf Medikamente will Deutschland Milliarden sparen. Derweil muss der Pharmakonzern die Bedenken der Anleger wegen Patentabläufen zerstreuen.

Read full article →

PERSPECTA

PERSPECTA

Novartis CEO criticizes German health reform: 'A wrong signal'

Sources

Novartis-Chef kritisiert die deutsche Gesundheitsreform: «Ein falsches Signal»

Related Stories

Twisha Sharma's Final Messages Revealed in Suicide Investigation

Russian Attacks Kill Ten in Ukraine, Air Defense Intercepts Drones

Trump's Diplomatic Engagements and Domestic Political Standing

Russia Threatens UK Over Ukraine's Use of British Drones in Attacks

PERSPECTA